Skip to content

Effects of Light vs. Heavy Paraffin Oil on Embryo Culture in IVF: A Prospective Study on Development and Pregnancy Rate

Effects of Light vs. Heavy Paraffin Oil on Embryo Culture in IVF: A Prospective Study on Development and Pregnancy Rate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06838923
Enrollment
818
Registered
2025-02-21
Start date
2023-05-23
Completion date
2025-01-15
Last updated
2025-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blastocyst IVF, Embryo Culture Media, Embryo Development, IVF, Pregnancy Rates

Keywords

heavy/light paraffin oil for embryo culture

Brief summary

This prospective study aims to compare the effects of light and heavy paraffin oil in embryo culture during in vitro fertilization (IVF). Paraffin oil is commonly used in IVF laboratories to protect embryo culture media from evaporation and temperature fluctuations. However, the impact of different oil viscosities on embryo development and pregnancy outcomes remains unclear. Participants undergoing IVF treatment will have their embryos cultured under either light or heavy paraffin oil conditions. The study will evaluate key outcomes, including embryo development, blastocyst formation rates, and pregnancy rates. Findings from this research may help optimize embryo culture conditions, potentially improving IVF success rates and guiding best laboratory practices.

Interventions

COMBINATION_PRODUCTLight Paraffin Oil

Embryos in this group will be cultured under conditions using light paraffin oil as an overlay in in vitro fertilization (IVF). The oil serves to protect the culture media from evaporation and temperature fluctuations. Key outcomes, including embryo development, blastocyst formation rate, and pregnancy rate, will be assessed.

COMBINATION_PRODUCTHeavy Paraffin Oil

Embryos in this group will be cultured under conditions using heavy paraffin oil as an overlay in in vitro fertilization (IVF). This study aims to compare the effects of heavy paraffin oil to light paraffin oil in embryo culture, assessing embryo development, blastocyst formation, and pregnancy rates.

Sponsors

Hung Vuong Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study employs a parallel assignment model, where participants undergoing in vitro fertilization (IVF) are randomly assigned to one of two groups. In the light paraffin oil group, embryos are cultured under conditions using light paraffin oil, while in the heavy paraffin oil group, embryos are cultured using heavy paraffin oil. The study aims to compare the effects of these two oil types on embryo development and pregnancy outcomes. Participants remain in their assigned group throughout the study without crossover between interventions. Key outcomes, including embryo development, blastocyst formation rate, and pregnancy rate, will be evaluated to determine which oil type provides optimal conditions for embryo culture in IVF.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Women undergoing in vitro fertilization (IVF) treatment with planned embryo culture. * Patients with normal ovarian function or undergoing ovarian stimulation for IVF. * Willingness to participate and provide informed consent.

Exclusion criteria

* Presence of severe uterine abnormalities (e.g., congenital malformations, Asherman's syndrome). * History of recurrent implantation failure (≥3 unsuccessful IVF attempts). * Poor ovarian response (e.g., ≤3 oocytes retrieved in a previous IVF cycle). * Presence of severe male factor infertility, requiring testicular sperm extraction (TESE) or micro-TESE. * Use of pre-implantation genetic testing (PGT) for embryo selection. * Known autoimmune disorders or uncontrolled chronic conditions (e.g., diabetes, thyroid disorders) that may affect pregnancy outcomes. * Participation in another clinical trial that may interfere with study outcomes. * Donor cycles or surrogacy.

Design outcomes

Primary

MeasureTime frameDescription
Fertilization Rate16-20 hours post-inseminationThe proportion of oocytes that successfully undergo fertilization after insemination, as determined by the presence of two pronuclei (2PN) at the appropriate time post-fertilization.
Cleavage Rate48 hours post-fertilizationThe proportion of fertilized oocytes that progress to cleavage-stage embryos, assessed by the number of embryos that reach at least the two-cell stage within 48 hours after fertilization.
Blastocyst Formation Rate5-6 days post-fertilizationThe proportion of embryos that successfully develop into blastocysts by Day 5 or Day 6 of culture, assessed based on morphological grading criteria.

Secondary

MeasureTime frameDescription
Ongoing Pregnancy Rate12 weeks post-embryo transferThe proportion of participants with a viable pregnancy continuing beyond the first trimester (≥12 weeks of gestation).
Positive Beta-hCG14 days post-embryo transferThe proportion of participants achieving a positive serum beta-hCG test, indicating biochemical pregnancy, measured approximately two weeks after embryo transfer.
Pregnancy Loss RateFrom positive beta-hCG until deliveryThe proportion of participants experiencing pregnancy loss at any stage
Live Birth RateAt delivery (up to ~40 weeks of gestation)The proportion of participants who achieve a live birth, defined as the delivery of a viable infant at ≥24 weeks of gestation.
Implantation Rate4-5 weeks post-embryo transferThe proportion of transferred embryos that successfully implant in the uterus, determined by the presence of a gestational sac on ultrasound.
Clinical Pregnancy Rate6-7 weeks post-embryo transferThe proportion of participants with ultrasound-confirmed pregnancy, defined by the presence of a gestational sac with fetal heartbeat.

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026